Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today broke...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, has doubled...
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today...
MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany a leading science and technology company, today announced ...
MilliporeSigma, the U.S. and Canada Life Science business sector of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today...
- MilliporeSigma's unique technology, ChetoSensar™, gives new promise to ADCs by alleviating solubility challenges - New DOLCORE™ platform increases...
Expansion in Carlsbad, California, USA, doubles production capacity to support commercialization and industrialization of viral vectors Investment...
MilliporeSigma, the U.S. and Canadian life science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, was selected ...
To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, MilliporeSigma has launched a new, high-purity synthetic ...
MilliporeSigma will add a single-use assembly production unit at its Life Science Center in Molsheim, France. With the $30 million investment, the...
MilliporeSigma today announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization...
MilliporeSigma today announced the broadening of its manufacturing footprint with a combined $47 million investment at its production facilities in...
MilliporeSigma today celebrated the topping-out ceremony for its new membrane production plant in Darmstadt, Germany. With the new facility, the...
MilliporeSigma today inaugurated a new $14.4 million industrial water treatment plant at its Jaffrey, New Hampshire, location. The upgraded system...
MilliporeSigma today announced a $65 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison,...
...
MilliporeSigma and Baylor College of Medicine today announced an extension of their ongoing collaboration to advance a manufacturing platform to...
MilliporeSigma, a leader in genome editing, today announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the...
MilliporeSigma and The Jenner Institute today announced that The Jenner Institute has laid the foundation for large-scale production of its Covid-19...
MilliporeSigma, a leader in genome editing, today announced that the United States Patent and Trademark Office has granted the company's patent for...
MilliporeSigma today launched its LANEXO™ Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution...
MilliporeSigma, a leader in genome editing, today announced that it has signed a license agreement providing Promega Corp., a global life science...
MilliporeSigma today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed its patent...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.